- Home
- IMUX vs SND Comparison
IMUX vs SND Comparison
Compare IMUX & SND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- SND
- Stock Information
- Founded
- IMUX 2016
- SND 2011
- Country
- IMUX United States
- SND United States
- Employees
- IMUX N/A
- SND N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- IMUX Health Care
- SND Industrials
- Exchange
- IMUX Nasdaq
- SND Nasdaq
- Market Cap
- IMUX 90.4M
- SND 92.1M
- IPO Year
- IMUX N/A
- SND 2016
- Fundamental
- Price
- IMUX $0.95
- SND $2.00
- Analyst Decision
- IMUX Strong Buy
- SND
- Analyst Count
- IMUX 5
- SND 0
- Target Price
- IMUX $7.50
- SND N/A
- AVG Volume (30 Days)
- IMUX 1.1M
- SND 103.7K
- Earning Date
- IMUX 08-07-2025
- SND 08-12-2025
- Dividend Yield
- IMUX N/A
- SND 5.00%
- EPS Growth
- IMUX N/A
- SND N/A
- EPS
- IMUX N/A
- SND 0.02
- Revenue
- IMUX N/A
- SND $305,848,000.00
- Revenue This Year
- IMUX N/A
- SND N/A
- Revenue Next Year
- IMUX N/A
- SND N/A
- P/E Ratio
- IMUX N/A
- SND $97.40
- Revenue Growth
- IMUX N/A
- SND 3.43
- 52 Week Low
- IMUX $0.56
- SND $1.76
- 52 Week High
- IMUX $2.11
- SND $2.80
- Technical
- Relative Strength Index (RSI)
- IMUX 53.93
- SND 55.72
- Support Level
- IMUX $0.89
- SND $1.94
- Resistance Level
- IMUX $1.00
- SND $2.04
- Average True Range (ATR)
- IMUX 0.08
- SND 0.08
- MACD
- IMUX -0.00
- SND 0.01
- Stochastic Oscillator
- IMUX 71.43
- SND 82.61
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About SND Smart Sand Inc.
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.